phosphocyclocreatine has been researched along with Brain Diseases, Metabolic, Familial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Class, B; Do, MT; Fisher, E; Frigeni, M; Gorshkov, K; Huang, W; Longo, N; Ottinger, EA; Singleton, M; Sun, W; Thorne, N; Wang, AQ; Xu, X; Zheng, W | 1 |
1 other study(ies) available for phosphocyclocreatine and Brain Diseases, Metabolic, Familial
| Article | Year |
|---|---|
Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Topics: Brain Diseases, Metabolic, Inborn; Cells, Cultured; Chromatography, High Pressure Liquid; Creatine; Creatinine; Fibroblasts; Humans; Imidazolidines; Mental Retardation, X-Linked; Phosphocreatine; Plasma Membrane Neurotransmitter Transport Proteins; Primary Cell Culture; Tandem Mass Spectrometry | 2019 |